Cinacalcet Hydrochloride Tablets 30 mg, 60 mg, 90 mg

What is Cinacalcet Hydrochloride Tablets 30 mg, 60 mg, 90 mg?

Cinacalcet Hydrochloride Tablets contain cinacalcet, a calcimimetic medicine used to help regulate parathyroid hormone (PTH) and calcium levels in specific disorders involving the parathyroid glands and chronic kidney disease. It is available in 30 mg, 60 mg, and 90 mg strengths for use according to the approved product information and specialist medical supervision.

Uses / Indications

Cinacalcet may be used for:

• Management of secondary hyperparathyroidism in adults with chronic kidney disease receiving dialysis.
• Reduction of elevated calcium levels in adults with parathyroid carcinoma.
• Management of severe hypercalcemia in adults with primary hyperparathyroidism when parathyroidectomy is not appropriate or has not provided adequate control, according to the applicable approved indication.

Benefits

• Helps reduce elevated parathyroid hormone levels in appropriate patients.
• Helps lower elevated serum calcium levels in specific hypercalcemic disorders.
• Acts on calcium-sensing receptors to help regulate parathyroid hormone secretion.
• Provides multiple strength options of 30 mg, 60 mg, and 90 mg for prescribed treatment regimens.

Side Effects

Common Side Effects

Possible side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Dizziness
• Weakness or fatigue
• Loss of appetite

Less Common or Serious Side Effects

Important adverse effects may include:

• Low blood calcium levels (hypocalcemia)
• Muscle cramps or spasms
• Tingling or numbness around the mouth or in the extremities
• Seizures in severe cases of hypocalcemia
• Changes in heart rhythm associated with significant reductions in calcium levels
• Serious allergic reactions

Patients receiving cinacalcet require appropriate monitoring of calcium levels.

How Does It Work?

Cinacalcet is a calcimimetic agent that increases the sensitivity of calcium-sensing receptors on parathyroid cells to extracellular calcium. This suppresses the secretion of parathyroid hormone. The resulting reduction in PTH can help lower circulating calcium and phosphorus-related abnormalities in appropriate clinical settings.

Dosage Guidelines

The appropriate cinacalcet dose depends on the indication, baseline calcium and PTH levels, response to treatment, kidney function, dialysis status, concurrent medicines, and individual clinical circumstances.

• Take the tablet exactly as prescribed.
• Cinacalcet tablets should be taken with or shortly after food.
• Swallow the tablet whole with water.
• Do not crush or divide the tablet unless specifically permitted by the approved product information.
• Regular monitoring of serum calcium and other relevant laboratory parameters is important during treatment.
• The 30 mg, 60 mg, and 90 mg strengths should be used only according to the prescribed treatment regimen.
• The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

Cinacalcet should not be used in:

• Patients with hypocalcemia.
• Individuals with known hypersensitivity to cinacalcet or any component of the formulation.

Cinacalcet should not be used for conditions outside its approved indications without appropriate specialist assessment.

Drug / Product Interactions

Clinically important interactions may occur with:

• Medicines that can lower serum calcium.
• Other medicines affecting calcium metabolism.
• Strong or moderate inhibitors or inducers of CYP3A4.
• Medicines metabolized through CYP2D6, as cinacalcet can inhibit CYP2D6 activity.
• Other medicines that may increase the risk of QT-interval prolongation, particularly when calcium levels become significantly reduced.

A complete medication review is recommended before starting or changing cinacalcet treatment.

Safety Advice

• Serum calcium should be monitored before and during treatment as clinically appropriate.
• Be alert for symptoms of hypocalcemia such as tingling, muscle cramps, spasms, or seizures.
• Patients with chronic kidney disease receiving dialysis require appropriate biochemical monitoring.
• Inform the healthcare professional about all medicines, supplements, and mineral products being taken.
• Use caution in patients with conditions or medicines that may increase the risk of low calcium levels.
• Pregnancy and breastfeeding should be discussed with a qualified healthcare professional before use.
• Children should receive cinacalcet only where specifically indicated and under appropriate specialist supervision.
• Older adults should be monitored according to their clinical condition and laboratory results.
• If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

General Instructions

• Take cinacalcet exactly according to the prescribed schedule.
• Take the tablet with food or shortly after a meal.
• Swallow the tablet whole with water.
• Do not change the strength or dose without professional guidance.
• Do not stop treatment without consulting the treating healthcare professional.
• Attend recommended laboratory monitoring appointments.
• If a dose is missed, follow the instructions provided by the healthcare professional or approved product information rather than taking an additional dose.
• Keep the tablets in their original packaging and out of reach of children.

Special Dietary / Lifestyle Tips

• Follow the calcium and phosphorus dietary recommendations provided by the treating healthcare professional.
• Do not independently start calcium, vitamin D, or phosphate-containing supplements without professional advice.
• Maintain adequate nutrition according to the dietary plan recommended for the underlying condition.
• Patients receiving dialysis should follow their prescribed dialysis schedule and dietary recommendations.
• Report symptoms that may indicate low calcium levels promptly.

Comparison with Other Treatments

Cinacalcet is a calcimimetic medicine that works by increasing the sensitivity of calcium-sensing receptors and reducing PTH secretion. Other approaches to managing hyperparathyroidism may include vitamin D analogues, phosphate-management therapies, calcium supplementation when indicated, or parathyroid surgery. The appropriate approach depends on the underlying condition, laboratory findings, treatment response, and clinical assessment.

Precautions & Warnings

• Cinacalcet treatment should not be initiated in patients with low serum calcium.
• Monitor calcium levels during treatment.
• Hypocalcemia may produce neuromuscular symptoms and, in severe cases, serious cardiac or neurological complications.
• Patients receiving dialysis require regular laboratory monitoring.
• Inform the healthcare professional about cardiovascular conditions or medicines that may affect cardiac rhythm.
• Do not independently use calcium or vitamin D products to manage symptoms without professional guidance.
• Pregnancy and breastfeeding require individual medical assessment.
• Seek immediate medical attention for severe muscle spasms, seizures, significant tingling, fainting, or other symptoms suggestive of severe hypocalcemia.

Can I Use It With Other Medicines?

Generally Compatible With

Cinacalcet can be incorporated into treatment regimens for appropriate patients when prescribed and monitored by a qualified healthcare professional. Combination therapy should be based on the underlying disorder and laboratory findings.

Use With Caution / Avoid

Particular caution may be required with:

• Medicines that lower serum calcium.
• Calcium and vitamin D therapies.
• Strong CYP3A4 inhibitors or inducers.
• Medicines metabolized by CYP2D6.
• Other medicines that may affect cardiac rhythm, particularly when calcium levels are low.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

• Keep the tablets in the original packaging.
• Protect from excessive heat, moisture, and light where applicable.
• Keep the pack properly closed when not in use.
• Keep out of reach of children.
• Do not use the product after its expiry date.

Frequently Asked Questions

1. What is Cinacalcet Hydrochloride Tablets used for?

Cinacalcet is used in specific disorders involving elevated parathyroid hormone and calcium levels, including secondary hyperparathyroidism in adults with chronic kidney disease receiving dialysis and certain cases of hypercalcemia associated with parathyroid disease.

2. What strengths of Cinacalcet Hydrochloride Tablets are available?

This product is available in 30 mg, 60 mg, and 90 mg tablet strengths.

3. How does cinacalcet work?

Cinacalcet increases the sensitivity of calcium-sensing receptors on parathyroid cells to calcium, thereby reducing parathyroid hormone secretion.

4. Why is calcium monitoring important during cinacalcet treatment?

Cinacalcet can lower serum calcium. Monitoring helps identify hypocalcemia and allows treatment to be adjusted appropriately when required.

5. How should Cinacalcet Tablets be taken?

Cinacalcet tablets should generally be taken with food or shortly after a meal and swallowed whole with water, according to the approved product information and prescribed regimen.

6. Can Cinacalcet be taken with calcium or vitamin D?

Calcium and vitamin D therapies may be used in some treatment regimens, but their use should be determined and monitored by the treating healthcare professional based on calcium, PTH, phosphorus, and other relevant laboratory results.

7. What are the common side effects of Cinacalcet?

Commonly reported effects include nausea, vomiting, diarrhea, dizziness, weakness, fatigue, and reduced appetite. Low calcium levels are an important adverse effect requiring monitoring.

8. What should I do if I miss a dose?

Follow the missed-dose instructions provided by the treating healthcare professional or the approved product information. Do not take an extra dose to compensate unless specifically instructed.